Closed · TI-16-014 · CFDA 93.243 · Discretionary
Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants
Federal grant opportunity posted by Substance Abuse and Mental Health Services Adminis, cataloged on Grants.gov.
- up to $1M
- Award range
- Closed
- Status
- May 31, 2016
- Close date
- 11
- Expected awards
The verdict
Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants is a closed discretionary listing from Substance Abuse and Mental Health Services Adminis that offered Up to $1,000,000 across 11 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 232 other opportunities from Substance Abuse and Mental Health Services Adminis.
- up to $1M
- award range
- Closed
- application status
- 11
- expected awards
- 93.243
- CFDA program
Archived opportunity record
Targeted Capacity Expansion: Medication Assis… is closed (last close May 31, 2016). The parent program page for CFDA 93.243 is the reliable place to catch re-announcements. Substance Abuse and Mental Health Services Adminis still indexes 232 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed May 31, 2016
Est. Total Funding
$11,000,000
Expected Awards
11
Instrument
Grant
Description
The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with opioid use disorder seeking or receiving MAT. This program targets states identified with having the highest rates of primary treatment admissions for heroin and opioids per capita, and prioritizes those states with the most dramatic increases for heroin and opioids, based on SAMHSA’s Treatment Episode Data Set (TEDS): 2007 - 2013. The desired outcomes include: 1) an increase in the number of admissions for MAT; 2) an increase in the number of clients receiving integrated care/treatment; 3) a decrease in illicit opioid drug use at 6-month follow-up; and 4) a decrease in the use of prescription opioids in a non-prescribed manner at 6-month follow-up. For the purpose of this FOA, integrated care/treatment is defined as the organized delivery and/or coordination of medical (including the use of Food and Drug Administration (FDA)-approved drugs [buprenorphine, methadone, naltrexone] for addiction), behavioral, social, peer, and other recovery support services provided to individual patients who have multiple healthcare needs in order to produce better overall health outcomes. MAT is defined as the use of FDA-approved opioid agonist medications (e.g., methadone, buprenorphine products, including buprenorphine/naloxone combination formulations and buprenorphine mono-product formulations) for the maintenance treatment of opioid use disorder and opioid antagonist medication (e.g., naltrexone products, including extended-release and oral formulations) in combination with behavioral therapies to prevent relapse to opioid use. MAT includes screening, assessment (which includes determination of severity of opioid use disorder, including presence of physical dependence and appropriateness for MAT), and case management. MAT is to be provided in combination with comprehensive substance use disorder treatment, including but not limited to: counseling, behavioral therapies, and, when needed, pharmacotherapy for co-occurring alcohol use disorder. MAT is to be provided in a clinically driven, person-centered, and individualized setting. This program addresses SAMHSA’s Strategic Initiative on Health Care and Health Systems Integration. For more information on SAMHSA’s six strategic initiatives, you can visit http://www.samhsa.gov/about-us/strategic-initiatives. The MAT-PDOA program seeks to address behavioral health disparities among racial, ethnic, sexual, and gender identity minority populations by encouraging the implementation of strategies to decrease the differences in access, service use, and outcomes among the racial and ethnic minority populations served. (See PART II: Appendix G – Addressing Behavioral Health Disparities.) The MAT-PDOA program is one of SAMHSA’s services grant programs. SAMHSA intends that its services grants result in the delivery of services as soon as possible after award. Service delivery should begin by the 4th month of the project at the latest.
Catch-all / unrestricted eligibility mark · TI-16-014
Grants.gov marks Targeted Capacity Expansion: Medication Assis… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Substance Abuse and Mental Health Services Adminis book (232 peers, 100% of 233).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Substance Abuse and Mental Health Services (SAMHSA)
U.S. Department of Health and Human Services
Agency Contact
Eileen Bermudez Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration (240) 276-1412
What to do next
Targeted Capacity Expansion: Medication Assis… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.243 may publish future NOFOs under the same assistance listing. Open program
- Substance Abuse and Mental Health Services indexes 0 Grants.gov listings in this extract. Program profile
- Substance Abuse and Mental Health Services Adminis lists 232 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |